DSNTV: Let’s get personal — breaking through in 140 characters
Consumers have access to more information than ever before, and that creates a new challenge for brands today, Thomas “TJ” Higgins, president, U.S. of Pfizer Consumer Healthcare told DSNTV in a special edition of DSN Executive Viewpoints. “The pressure is on our brand teams today to get more information [to the consumer]. We have to get more specific, more personalized,” Higgins said. “As the consumer has access to more information, they want to know not what’s good for the general population, but what’s good for me? [We] need to be much more specific to the consumer — to the user, to the experiences they’re having everyday and how our product fits very specifically into that need state.”
And in the age of social media, where consumers communicate in tweets and pins, brands better be able to make the pitch short and sweet. “We have to be much more efficient; we have to be much more clear,” he added. “We live in a 140-character kind of environment today, so we have to be tight [with our message]. We’re used to telling stories in 30 seconds or on pages in a magazine; now we have 140 characters.”
For more, including how Pfizer is bringing innovation to its existing brands to deliver greater value in a tight economy, best practices for growing the business and how the company is helping its retailer partners evolve the customer relationship beyond the old transaction-based model, click below to see the complete video.
No comments found
FDA issues fentanyl patch disposal guidelines
NEW YORK — Nearly 30 children have been accidentally poisoned by opioid painkiller patches since 1997, according to the Food and Drug Administration, prompting the agency to issue disposal guidelines.
The FDA listed the guidelines on its website, saying that unused fentanyl patches should be stored out of the reach and sight of children, while used patches should be folded, sticky sides together, and flushed down the toilet.
Of the 26 children poisoned by fentanyl patches between 1997 and 2012, 10 died, according to the agency.
No comments found
AMA adopts resolution on pharmacist drug inquiries
NEW YORK — Inquiries by pharmacists with doctors regarding the rationale behind prescriptions, diagnoses and treatment plans are inappropriate, according to a new resolution by the American Medical Association.
The AMA adopted the resolution at its 2013 annual meeting, calling such inquiries "an interference with the practice of medicine and unwarranted."
According to the National Association of Boards of Pharmacy, the Drug Enforcement Administration has reminded pharmacists of their responsibility to ensure that prescriptions for controlled substances are in compliance with federal law and to prevent drug diversion.
The AMA said it would work with such groups as the National Association of Chain Drug Stores to engage with the DEA and the Department of Justice to develop an "appropriate policy for pharmacists to work with physicians in order to reduce the incidence of drug diversion and inappropriate dispensing."
The actions taken by for-profit unaccredited medical schools are making it difficult for U.S. medical and osteopathic medical schools to secure clinical training sites for their students in U.S. hospitals. - Adam Gottbetter
NCPA opposes this resolution. While we appreciate the changes AMA made to the original proposed resolution, the final resolution is still problematic. Read NCPA's take here: http://ncpanet.wordpress.com/2013/06/25/ncpa-weighs-in-on-amas-pharmacist-resolution/
The actions taken by the AMA House of Delegates call attention to an important issue, but don’t address the real problem or offer solutions for patients and regulators. A pharmacist asking too many questions of their physician colleagues is just a symptom of a larger issue: the US faces a major public health epidemic with prescription drug abuse – in particular opioid abuse. It is not pharmacy's intent to delay patients from receiving these needed medications or to unnecessarily interrupt prescribers. The current situation highlights the need for pharmacy, medicine and regulators to collaborate on solutions that address the root cause abuse problems and health care system inefficiencies in this country. Tom Menighan offers more insight on this resolution passage on his CEO Blog: http://www.pharmacist.com/CEOBlog/more-pharmacist-physician-collaboration-not-less
I work in California. A prescription is a request to fill a prescription or verify and hospital chart order. It is not a command to do what ever I say. The pharmacist's responsibility is to ensure the drug request is correct and safe on many levels. I believe most pharmacist will continue to do this irregardless of what the AMA says.